James Laird, MD
Assistant Professor of Therapeutic RadiologyCards
Are You a Patient?
View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.
View Doctor ProfileContact Info
Therapeutic Radiology
P.O. Box 208040
New Haven, CT 06520-8040
United States
About
Titles
Assistant Professor of Therapeutic Radiology
Biography
Dr. James Laird is an Assistant Professor of Therapeutic Radiology and sees patients at Smilow Cancer Hospital in Waterford. Dr. Laird received his medical degree from New York University School of Medicine, where he was inducted into the Alpha Omega Alpha honor society and named the highest performing student in the preclinical curriculum. He completed his residency in radiation oncology at Yale, and served as the Chief Resident for the 2022-2023 academic year.
Dr. Laird's clinical practice includes treatment of thoracic, head and neck, gastrointestinal, skin, and gynecologic malignancies. His current research interests include the role of local treatments in oligometastatic cancer.
Appointments
Therapeutic Radiology
Assistant ProfessorPrimary
Other Departments & Organizations
- Therapeutic Radiology
- Yale Cancer Center
- Yale Medicine
Education & Training
- Resident
- Yale New Haven Hospital (2023)
- Intern
- Lenox Hill Hospital (2019)
- MD
- New York University School of Medicine (2018)
- BA
- Columbia University (2013)
Research
Research at a Glance
Yale Co-Authors
Publications Timeline
Melissa Rasar Young, MD, PhD
James B. Yu, MD, MHS, FASTRO
Jonathan Leventhal, MD
Shari Damast, MD
Yi An, MD
Publications
2023
Radiation Pneumonitis
Laird J, Decker R, Roberts K, Park H. Radiation Pneumonitis. In: Grippi M, Antin-Ozerkis D, Dela Cruz C, Kotloff R, Kotton C, Pack A (editors). Fishman’s Pulmonary Diseases and Disorders, 6th edition. New York: McGraw-Hill: 2023; p. 966-986.Chapters
2022
Early Laryngeal Cancer
Crosby T, Laird J, Park H, McWharter A. Early Laryngeal Cancer. In: Johnson J and Rosen C (editors). Bailey’s Head & Neck Surgery Otolaryngology, 6th Edition. Philadelphia: LWW: 2022; Chapter 141.Chapters
2021
Radiation Recall Dermatitis After Capecitabine in a Patient With Triple Negative Breast Cancer
Laird J, Leventhal J, Kanowitz J, Damast S. Radiation Recall Dermatitis After Capecitabine in a Patient With Triple Negative Breast Cancer. Practical Radiation Oncology 2021, 11: 448-452. PMID: 34157449, DOI: 10.1016/j.prro.2021.06.001.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsDrivers of Medicare Spending: A 15-Year Review of Radiation Oncology Charges Allowed by the Medicare Physician/Supplier Fee-for-Service Program Compared With Other Specialties
Mokhtech M, Laird JH, Maroongroge S, Zhu D, Falit B, Johnstone PAS, Mantz CA, Ennis RD, Sandler HM, Dosoretz AP, Yu JB. Drivers of Medicare Spending: A 15-Year Review of Radiation Oncology Charges Allowed by the Medicare Physician/Supplier Fee-for-Service Program Compared With Other Specialties. International Journal Of Radiation Oncology • Biology • Physics 2021, 110: 322-327. PMID: 33412264, DOI: 10.1016/j.ijrobp.2020.12.051.Peer-Reviewed Original ResearchCitationsAltmetric
2020
Ovarian Cancer
Laird J, Tymon-Rosario J, Damast S. Ovarian Cancer. 2020 DOI: 10.1891/9780826155146.0026.ChaptersEndometrial Cancer
Laird J, An Y, Damast S. Endometrial Cancer. 2020 DOI: 10.1891/9780826155146.0027.ChaptersCervical Cancer
Laird J, Young M, Damast S. Cervical Cancer. 2020 DOI: 10.1891/9780826155146.0028.ChaptersVulvar Cancer
Laird J, Young M, Damast S. Vulvar Cancer. 2020 DOI: 10.1891/9780826155146.0030.Chapters
2019
Positron-Emission Tomographic Imaging of a Fluorine 18–Radiolabeled Poly(ADP-Ribose) Polymerase 1 Inhibitor Monitors the Therapeutic Efficacy of Talazoparib in SCLC Patient–Derived Xenografts
Laird J, Lok B, Carney B, Kossatz S, de Stanchina E, Reiner T, Poirier J, Rudin C. Positron-Emission Tomographic Imaging of a Fluorine 18–Radiolabeled Poly(ADP-Ribose) Polymerase 1 Inhibitor Monitors the Therapeutic Efficacy of Talazoparib in SCLC Patient–Derived Xenografts. Journal Of Thoracic Oncology 2019, 14: 1743-1752. PMID: 31195178, PMCID: PMC6764879, DOI: 10.1016/j.jtho.2019.05.032.Peer-Reviewed Original ResearchCitationsMeSH Keywords and ConceptsMeSH KeywordsAnimalsApoptosisCell ProliferationFemaleFluorine RadioisotopesHumansLung NeoplasmsMiceMice, Inbred NODMice, SCIDPhthalazinesPoly (ADP-Ribose) Polymerase-1Poly(ADP-ribose) Polymerase InhibitorsPositron-Emission TomographyRadiopharmaceuticalsSmall Cell Lung CarcinomaTumor Cells, CulturedXenograft Model Antitumor AssaysConceptsPatient-derived xenograftsPositron emission tomographicPARP inhibitorsTherapeutic efficacyTarget engagementPositron emission tomographic imagingDifferential therapeutic efficacyTumor radiotracer uptakeTumor growth inhibitionEnzyme-linked immunosorbentDose-dependent mannerFluorine-18Oral talazoparibMultiple dosesSingle dosesTotal tumorsPolymerase-1 (PARP-1) inhibitorsPET uptakeRadiotracer uptakeInhibitor of polyIndividual tumorsPET/Drug efficacyTalazoparib treatmentPromising therapeutics
Clinical Care
Overview
Clinical Specialties
Fact Sheets
Throat Cancer
Learn More on Yale MedicineMetastatic Cancer
Learn More on Yale MedicineNon-Small Cell Lung Cancer
Learn More on Yale MedicineRadiofrequency Ablation (RFA)
Learn More on Yale Medicine
Yale Medicine News
Are You a Patient?
View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.
View Doctor ProfileGet In Touch
Contacts
Therapeutic Radiology
P.O. Box 208040
New Haven, CT 06520-8040
United States
Locations
Patient Care Locations
Are You a Patient? View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.